FARALLON CAPITAL MANAGEMENT, L.L.C.
Follow13F filer, CIK 909661, SAN FRANCISCO, CA
FARALLON CAPITAL MANAGEMENT, L.L.C. reported $21,675,731,270 across 89 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14. Its ten largest share positions make up 55.71% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000908834-26-000432
- Period
- 2026-06-30
- Reported value
- $21.7B
- Holdings
- 89
- Top 10 weight
- 55.71%
- New
- 23
- Sold out
- 107
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| IMVTadded | +4,259,000 | $164M |
| ROIVadded | +4,634,000 | $164M |
| BSXadded | +3,050,500 | $130M |
| BBIOadded | +1,377,600 | $103M |
| TNGXadded | +3,179,589 | $99.4M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| MSFTreduced | -1,231,916 | -$460M |
| AMZNreduced | -1,585,400 | -$378M |
| AONreduced | -1,130,076 | -$375M |
| SCHWexited | -3,955,657 | -$372M |
| GOOGexited | -996,231 | -$286M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Back to all 82 share positions
Options
Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).
Principal amounts
Notes and convertibles filed as a face amount (PRN). A face amount is never added to a share count (H6).
| Security | Type | Amount | Value | Change |
|---|---|---|---|---|
| STRATEGY INCSTRATEGY INC NOTE12/0 | principal | 87,858,000 | $75.4M | +48,358,000 |
| VNET GROUP INCVNET GROUP INC NOTE 2.000%10/0 | principal | 45,000,000 | $46.8M | 0 |
| STRATEGY INCSTRATEGY INC NOTE 2.250% 6/1 | principal | 15,000,000 | $14.2M | new |
| STRATEGY INCSTRATEGY INC NOTE 3/0 | principal | 2,632,000 | $2.32M | new |
Sold out in Q2 2026
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| STATE STR SPDR S&P 500 ETF TSTATE STR SPDR S&P 500 ETF T | 2,300,000 | $1.5B | put |
| INVESCO EXCHANGE TRADED FD TINVESCO EXCHANGE TRADED FD T | 3,600,000 | $691M | put |
| SCHWCHARLES SCHWAB CORP (THE) | 3,955,657 | $372M | shares |
| GOOGALPHABET INC | 996,231 | $286M | shares |
| VVISA INC | 840,710 | $254M | shares |
| DISDISNEY WALT CO | 2,401,591 | $231M | shares |
| MAMASTERCARD INCORPORATED | 435,071 | $217M | shares |
| MCKMCKESSON CORP | 234,300 | $203M | shares |
| CNTACENTESSA PHARMACEUTICALS PLC | 4,809,000 | $191M | shares |
| TYRATYRA BIOSCIENCES INC | 3,580,818 | $137M | shares |
| THCTENET HEALTHCARE CORP | 452,153 | $85.3M | shares |
| CAHCARDINAL HEALTH INC | 368,000 | $77.8M | shares |
| PCVXVAXCYTE INC | 1,261,000 | $73.3M | shares |
| DNTHDIANTHUS THERAPEUTICS INC | 836,000 | $70.2M | shares |
| CGONCG ONCOLOGY INC | 674,000 | $45.6M | shares |
| BITWBITWISE 10 CRYPTO INDEX ETF | 603,000 | $26.9M | shares |
| RPRXROYALTY PHARMA PLC | 493,000 | $23.6M | shares |
| CECOCECO ENVIRONMENTAL CORP | 234,000 | $13.9M | shares |
| CG ONCOLOGY INCCG ONCOLOGY INC | 200,000 | $13.5M | call |
| GDSGDS HLDGS LTD | 292,000 | $11.8M | shares |
| FORMFORMFACTOR INC | 56,500 | $5.48M | shares |
| MTZMASTEC INC | 17,000 | $5.47M | shares |
| ENTGENTEGRIS INC | 45,500 | $5.33M | shares |
| CCITIGROUP INC | 47,000 | $5.33M | shares |
| HHYATT HOTELS CORP | 36,000 | $5.18M | shares |
| WALWESTERN ALLIANCE BANCORP | 73,000 | $5.17M | shares |
| TKRTIMKEN CO | 51,000 | $5.13M | shares |
| FLEXFLEX LTD | 78,000 | $5.11M | shares |
| SPGIS&P GLOBAL INC | 12,000 | $5.1M | shares |
| LFUSLITTELFUSE INC | 15,000 | $5.09M | shares |
| PIPRPIPER SANDLER COMPANIES | 66,000 | $5.05M | shares |
| AIRAAR CORP | 46,000 | $5.04M | shares |
| GTXGARRETT MOTION INC | 275,000 | $5M | shares |
| ROLROLLINS INC | 93,000 | $4.97M | shares |
| AFRMAFFIRM HLDGS INC | 108,000 | $4.95M | shares |
| INTRINTER & CO INC | 614,500 | $4.89M | shares |
| CMICUMMINS INC | 9,000 | $4.84M | shares |
| FISVFISERV INC | 86,000 | $4.8M | shares |
| VRTVERTIV HOLDINGS CO | 19,000 | $4.76M | shares |
| AMKRAMKOR TECHNOLOGY INC | 104,000 | $4.68M | shares |
| RNAATRIUM THERAPEUTICS INC | 349,360 | $4.67M | shares |
| GFSGLOBALFOUNDRIES INC | 105,000 | $4.67M | shares |
| MOHMOLINA HEALTHCARE INC | 35,000 | $4.67M | shares |
| IRDOPUS GENETICS INC | 1,000,000 | $4.55M | shares |
| TENBTENABLE HLDGS INC | 265,000 | $4.48M | shares |
| NOWSERVICENOW INC | 41,000 | $4.29M | shares |
| MDGLMADRIGAL PHARMACEUTICALS INC | 3,319 | $1.74M | shares |
| CAPRCAPRICOR THERAPEUTICS INC | 41,000 | $1.25M | shares |
| ARWRARROWHEAD PHARMACEUTICALS IN | 15,800 | $991K | shares |
| ALKSALKERMES PLC | 20,800 | $735K | shares |
| AXSMAXSOME THERAPEUTICS INC. | 4,000 | $676K | shares |
| ARQTARCUTIS BIOTHERAPEUTICS INC | 26,000 | $613K | shares |
| CELCCELCUITY INC | 4,000 | $457K | shares |
| LIVNLIVANOVA PLC | 6,000 | $381K | shares |
| TERNTERNS PHARMACEUTICALS INC | 7,000 | $369K | shares |
| IONSIONIS PHARMACEUTICALS INC | 4,800 | $360K | shares |
| TVTXTRAVERE THERAPEUTICS INC | 12,000 | $357K | shares |
| GMEDGLOBUS MED INC | 4,000 | $345K | shares |
| SRRKSCHOLAR ROCK HLDG CORP | 7,000 | $344K | shares |
| ONCBEONE MEDICINES LTD | 1,100 | $327K | shares |
| WGSGENEDX HOLDINGS CORP | 5,000 | $321K | shares |
| CORCENCORA INC | 1,000 | $314K | shares |
| NUVLNUVALENT INC | 3,000 | $307K | shares |
| PGNYPROGYNY INC | 18,000 | $306K | shares |
| STOKSTOKE THERAPEUTICS INC | 9,000 | $293K | shares |
| ERASERASCA INC | 18,000 | $291K | shares |
| EHCENCOMPASS HEALTH CORP | 3,000 | $290K | shares |
| NKTRNEKTAR THERAPEUTICS | 4,000 | $288K | shares |
| GKOSGLAUKOS CORP | 2,600 | $280K | shares |
| MIRMMIRUM PHARMACEUTICALS INC | 3,000 | $277K | shares |
| SBRASABRA HEALTH CARE REIT INC | 14,000 | $269K | shares |
| KRYSKRYSTAL BIOTECH INC | 1,000 | $258K | shares |
| OMEROMEROS CORP | 23,000 | $243K | shares |
| ALMSALUMIS INC | 11,000 | $242K | shares |
| APLSAPELLIS PHARMACEUTICALS INC | 6,000 | $241K | shares |
| HQYHEALTHEQUITY INC | 2,800 | $234K | shares |
| SNDXSYNDAX PHARMACEUTICALS INC | 10,000 | $234K | shares |
| FOLDAMICUS THERAPEUTIC | 16,000 | $231K | shares |
| QUREUNIQURE NV | 14,000 | $229K | shares |
| BCRXBIOCRYST PHARMACEUTICALS INC | 24,000 | $228K | shares |
| VCYTVERACYTE INC | 7,000 | $225K | shares |
| GRFSGRIFOLS S A | 28,000 | $225K | shares |
| GEHCGE HEALTHCARE TECHNOLOGIES I | 3,000 | $214K | shares |
| HIMSHIMS & HERS HEALTH INC | 10,000 | $208K | shares |
| BLTEBELITE BIO INC | 1,300 | $207K | shares |
| MMSIMERIT MED SYS INC | 3,000 | $207K | shares |
| SUPNSUPERNUS PHARMACEUTICALS | 4,000 | $207K | shares |
| HRHEALTHCARE RLTY TR | 12,000 | $204K | shares |
| URGNUROGEN PHARMA LTD | 11,000 | $198K | shares |
| VIRVIR BIOTECHNOLOGY INC | 22,000 | $197K | shares |
| PGENPRECIGEN INC | 50,000 | $194K | shares |
| SDGRSCHRODINGER INC | 17,000 | $193K | shares |
| DYNDYNE THERAPEUTICS INC | 10,000 | $181K | shares |
| NVAXNOVAVAX INC | 22,000 | $179K | shares |
| SLSSELLAS LIFE SCIENCES GROUP I | 40,000 | $169K | shares |
| ADPTADAPTIVE BIOTECHNOLOGIES COR | 11,000 | $153K | shares |
| OCULOCULAR THERAPEUTIX INC | 18,000 | $152K | shares |
| NEONEOGENOMICS INC | 19,000 | $141K | shares |
| ARDXARDELYX INC | 23,000 | $138K | shares |
| OSCROSCAR HEALTH INC | 11,000 | $126K | shares |
| NUVBNUVATION BIO INC | 29,000 | $124K | shares |
| IOVAIOVANCE BIOTHERAPEUTICS INC | 26,000 | $91.3K | shares |
| ALTALTIMMUNE INC | 27,600 | $85K | shares |
| CCCCC4 THERAPEUTICS INC | 28,000 | $73.6K | shares |
| TVRDTVARDI THERAPEUTICS INC | 21,438 | $68.2K | shares |
| IRWDIRONWOOD PHARMACEUTICALS INC | 13,000 | $45.6K | shares |
| EVHEVOLENT HEALTH INC | 14,000 | $31.9K | shares |
How Q2 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000908834-26-000432 | base | 2026-08-14 | acceptance time not in the bulk data set |